- 11 months ago
11 April 2023
The Department of Health and Ageing has released a nine month consultation plan for the Health Technology Assessment (HTA) Review, marking the official start of the process.
From 11 April to 6 June 2023, the Review will seek engagement “to provide early guidance into the review focused on the key objectives”.
The review reference committee will also conduct ‘deep dives’ with experts in HTA as well as industry, patients and consumers, “parallel policy reform areas”, international counterparts, and clinical and academic groups.
Medicines Australia welcomed the start, CEO Liz de Somer saying after 30 years “it is long past time for reform to the HTA policies and methods to ensure Australians have timely access to the latest medicines and vaccines”.
“We are all patients at one point in our lives and our PBS, as part of our Medicare system should provide access to the innovative medicines, treatments and services that are needed as quickly as possible,” she said.
“Access should be fair and equitable, regardless of ability to pay or capacity to research what may already be available overseas.
“This consultation signals the start of a reform process that must introduce long-term thinking to speed up access to innovative medicines for today’s generation and the next.”
De Somer encouraged everyone to get involved, saying, “Substantial, enduring change cannot happen without the input and insights from everyone across the health and medicine landscape”.